SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001311547-04-000001
Filing Date
2004-12-17
Accepted
2004-12-17 14:48:09
Documents
1
Period of Report
2004-12-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1491
  Complete submission text file 0001311547-04-000001.txt   3252
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 SOUTHWICK COURT NORTH PLAINVIEW NY 11803
Business Address 516-428-8575
Dobroff Lawrence (Reporting) CIK: 0001311547 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19879 | Film No.: 041211077